Fibroblast growth factor 21 is induced by endoplasmic reticulum stress

Biochimie

Volumn 95, Issue 4, 2013, Pages 692-699

  Schaap, Frank G ^a   Kremer, Andreas E ^a,b   Lamers, Wouter H ^a   Jansen, Peter L M ^a   Gaemers, Ingrid C ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Non alcoholic fatty liver disease; Stress signaling; Unfolded protein response

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; FIBROBLAST GROWTH FACTOR 21; INITIATION FACTOR 2ALPHA; MESSENGER RNA; TUNICAMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; COMPUTER MODEL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; GENE OVEREXPRESSION; HEPATOMA CELL; LIVER CELL; MALE; MOUSE; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; NONHUMAN; NUTRIENT; PROMOTER REGION; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UNFOLDED PROTEIN RESPONSE;

ACTIVATING TRANSCRIPTION FACTOR 4; AMINO ACID SEQUENCE; ANIMALS; ENDOPLASMIC RETICULUM STRESS; FIBROBLAST GROWTH FACTORS; HEK293 CELLS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; RATS; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; THAPSIGARGIN; TRANSCRIPTIONAL ACTIVATION; TUNICAMYCIN; UNFOLDED PROTEIN RESPONSE;

MUS; RATTUS;

EID: 84874664386     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.10.019     Document Type: Article

References (51)

1. T. Inagaki, P. Dutchak, G. Zhao, X. Ding, L. Gautron, V. Parameswara, Y. Li, R. Goetz, M. Mohammadi, V. Esser, J.K. Elmquist, R.D. Gerard, S.C. Burgess, R.E. Hammer, D.J. Mangelsdorf, and S.A. Kliewer Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21 Cell. Metab. 5 2007 415 425
2. J. Xu, D.J. Lloyd, C. Hale, S. Stanislaus, M. Chen, G. Sivits, S. Vonderfecht, R. Hecht, Y.S. Li, R.A. Lindberg, J.L. Chen, D.Y. Jung, Z. Zhang, H.J. Ko, J.K. Kim, and M.M. Veniant Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice Diabetes 58 2009 250 259
3. M.K. Badman, P. Pissios, A.R. Kennedy, G. Koukos, J.S. Flier, and E. Maratos-Flier Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states Cell. Metab. 5 2007 426 437
4. A. Kharitonenkov, T.L. Shiyanova, A. Koester, A.M. Ford, R. Micanovic, E.J. Galbreath, G.E. Sandusky, L.J. Hammond, J.S. Moyers, R.A. Owens, J. Gromada, J.T. Brozinick, E.D. Hawkins, V.J. Wroblewski, D.S. Li, F. Mehrbod, S.R. Jaskunas, and A.B. Shanafelt FGF-21 as a novel metabolic regulator J. Clin. Invest. 115 2005 1627 1635
5. A. Kharitonenkov, and P. Larsen FGF21 reloaded: challenges of a rapidly growing field Trends Endocrinol. Metab. 22 2011 81 86
6. S.A. Kliewer, and D.J. Mangelsdorf Fibroblast growth factor 21: from pharmacology to physiology Am. J. Clin. Nutr. 91 2010 254S 257S
7. A. Kharitonenkov, V.J. Wroblewski, A. Koester, Y.F. Chen, C.K. Clutinger, X.T. Tigno, B.C. Hansen, A.B. Shanafelt, and G.J. Etgen The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21 Endocrinology 148 2007 774 781
8. J. Mu, J. Pinkstaff, Z. Li, L. Skidmore, N. Li, H. Myler, Q. Dallas-Yang, A.M. Putnam, J. Yao, S. Bussell, M. Wu, T.C. Norman, C.G. Rodriguez, B. Kimmel, J.M. Metzger, A. Manibusan, D. Lee, D.M. Zaller, B.B. Zhang, R.D. Dimarchi, J.P. Berger, and D.W. Axelrod FGF21 analogs of sustained action enabled by orthogonal biosynthesis demonstrate enhanced antidiabetic pharmacology in rodents Diabetes 61 2012 505 512
9. A.L. Wu, G. Kolumam, S. Stawicki, Y. Chen, J. Li, J. Zavala-Solorio, K. Phamluong, B. Feng, L. Li, S. Marsters, L. Kates, B.N. van, M. Leabman, A. Wong, D. West, H. Stern, E. Luis, H.S. Kim, D. Yansura, A.S. Peterson, E. Filvaroff, Y. Wu, and J. Sonoda Amelioration of type 2 diabetes by antibody-mediated activation of fibroblast growth factor receptor 1 Sci. Transl. Med. 3 2011 113ra126
10. Z. Huang, H. Wang, M. Lu, C. Sun, X. Wu, Y. Tan, C. Ye, G. Zhu, X. Wang, L. Cai, and X. Li A better anti-diabetic recombinant human fibroblast growth factor 21 (rhFGF21) modified with polyethylene glycol PLoS One 6 2011 e20669
11. J. Dushay, P.C. Chui, G.S. Gopalakrishnan, M. Varela-Rey, M. Crawley, F.M. Fisher, M.K. Badman, M.L. Martinez-Chantar, and E. Maratos-Flier Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease Gastroenterology 139 2010 456 463
12. H. Li, Q. Fang, F. Gao, J. Fan, J. Zhou, X. Wang, H. Zhang, X. Pan, Y. Bao, K. Xiang, A. Xu, and W. Jia Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride J. Hepatol. 53 2010 934 940
13. Y. Yilmaz, F. Eren, O. Yonal, R. Kurt, B. Aktas, C.A. Celikel, O. Ozdogan, N. Imeryuz, C. Kalayci, and E. Avsar Increased serum FGF21 levels in patients with nonalcoholic fatty liver disease Eur. J. Clin. Invest. 40 2010 887 892
14. P.L. Jansen, J. van Werven, E. Aarts, F. Berends, I. Janssen, J. Stoker, and F.G. Schaap Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery Dig. Dis. 29 2011 48 51
15. G.C. Farrell, and C.Z. Larter Nonalcoholic fatty liver disease: from steatosis to cirrhosis Hepatology 43 2006 S99 S112
16. F.M. Fisher, P.C. Chui, P.J. Antonellis, H.A. Bina, A. Kharitonenkov, J.S. Flier, and E. Maratos-Flier Obesity is a fibroblast growth factor 21 (FGF21)-resistant state Diabetes 59 2010 2781 2789
17. I.C. Gaemers, J.M. Stallen, C. Kunne, C. Wallner, J. van Werven, A. Nederveen, and W.H. Lamers Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease Biochim. Biophys. Acta 1812 2011 447 458
18. C. Hale, M.M. Chen, S. Stanislaus, N. Chinookoswong, T. Hager, M. Wang, M.M. Veniant, and J. Xu Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance Endocrinology 153 2012 69 80
19. P. Puri, F. Mirshahi, O. Cheung, R. Natarajan, J.W. Maher, J.M. Kellum, and A.J. Sanyal Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease Gastroenterology 134 2008 568 576
20. H. Malhi, and R.J. Kaufman Endoplasmic reticulum stress in liver disease J. Hepatol. 54 2011 795 809
21. C. Hetz, F. Martinon, D. Rodriguez, and L.H. Glimcher The unfolded protein response: integrating stress signals through the stress sensor IRE1alpha Physiol. Rev. 91 2011 1219 1243
22. G.S. Hotamisligil Inflammation and endoplasmic reticulum stress in obesity and diabetes Int. J. Obes. (Lond.) 32 Suppl. 7 2008 S52 S54
23. D. Ron, and P. Walter Signal integration in the endoplasmic reticulum unfolded protein response Nat. Rev. Mol. Cell. Biol. 8 2007 519 529
24. D.T. Rutkowski, and R.S. Hegde Regulation of basal cellular physiology by the homeostatic unfolded protein response J. Cell. Biol. 189 2010 783 794
25. H. Tyynismaa, C.J. Carroll, N. Raimundo, S. Ahola-Erkkila, T. Wenz, H. Ruhanen, K. Guse, A. Hemminki, K.E. Peltola-Mjosund, V. Tulkki, M. Oresic, C.T. Moraes, K. Pietilainen, I. Hovatta, and A. Suomalainen Mitochondrial myopathy induces a starvation-like response Hum. Mol. Genet. 19 2010 3948 3958
26. T.L. Cameron, K.M. Bell, L. Tatarczuch, E.J. Mackie, M.H. Rajpar, B.T. McDermott, R.P. Boot-Handford, and J.F. Bateman Transcriptional profiling of chondrodysplasia growth plate cartilage reveals adaptive ER-stress networks that allow survival but disrupt hypertrophy PLoS One 6 2011 e24600
27. T. Osawa, M. Muramatsu, M. Watanabe, and M. Shibuya Hypoxia and low-nutrition double stress induces aggressiveness in a murine model of melanoma Cancer Sci. 100 2009 844 851
28. Y. Wang, L.A. Solt, and T.P. Burris Regulation of FGF21 expression and secretion by retinoic acid receptor-related orphan receptor alpha J. Biol. Chem. 285 2010 15668 15673
29. F. Siu, P.J. Bain, R. LeBlanc-Chaffin, H. Chen, and M.S. Kilberg ATF4 is a mediator of the nutrient-sensing response pathway that activates the human asparagine synthetase gene J. Biol. Chem. 277 2002 24120 24127
30. R.N. Vellanki, L. Zhang, M.A. Guney, J.V. Rocheleau, M. Gannon, and A. Volchuk OASIS/CREB3L1 induces expression of genes involved in extracellular matrix production but not classical endoplasmic reticulum stress response genes in pancreatic beta-cells Endocrinology 151 2010 4146 4157
31. R.P. Oude Elferink, R. Ottenhoff, W. Liefting, J. de Haan, and P.L. Jansen Hepatobiliary transport of glutathione and glutathione conjugate in rats with hereditary hyperbilirubinemia J. Clin. Invest. 84 1989 476 483
32. F.G. Schaap, N.A. van der Gaag, D.J. Gouma, and P.L. Jansen High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis Hepatology 49 2009 1228 1235
33. J.M. Ruijter, H.H. Thygesen, O.J. Schoneveld, A.T. Das, B. Berkhout, and W.H. Lamers Factor correction as a tool to eliminate between-session variation in replicate experiments: application to molecular biology and retrovirology Retrovirology 3 2006 2
34. J.H. Reiling, C.B. Clish, J.E. Carette, M. Varadarajan, T.R. Brummelkamp, and D.M. Sabatini A haploid genetic screen identifies the major facilitator domain containing 2A (MFSD2A) transporter as a key mediator in the response to tunicamycin Proc. Natl. Acad. Sci. U.S.A. 108 2011 11756 11765
35. G.G. Loots, and I. Ovcharenko rVISTA 2.0: evolutionary analysis of transcription factor binding sites Nucleic Acids Res. 32 2004 W217 W221
36. K. Cartharius, K. Frech, K. Grote, B. Klocke, M. Haltmeier, A. Klingenhoff, M. Frisch, M. Bayerlein, and T. Werner MatInspector and beyond: promoter analysis based on transcription factor binding sites Bioinformatics 21 2005 2933 2942
37. R.C. Wek, H.Y. Jiang, and T.G. Anthony Coping with stress: eIF2 kinases and translational control Biochem. Soc. Trans. 34 2006 7 11
38. M.S. Kilberg, J. Shan, and N. Su ATF4-dependent transcription mediates signaling of amino acid limitation Trends Endocrinol. Metab. 20 2009 436 443
39. M. Rafie-Kolpin, A.P. Han, and J.J. Chen Autophosphorylation of threonine 485 in the activation loop is essential for attaining eIF2alpha kinase activity of HRI Biochemistry 42 2003 6536 6544
40. A.L. De Sousa-Coelho, P.F. Marrero, and D. Haro Activating transcription factor 4-dependent induction of FGF21 during amino acid deprivation Biochem. J. 443 2012 165 171
41. U. Ozcan, Q. Cao, E. Yilmaz, A.H. Lee, N.N. Iwakoshi, E. Ozdelen, G. Tuncman, C. Gorgun, L.H. Glimcher, and G.S. Hotamisligil Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes Science 306 2004 457 461
42. M. Shuda, N. Kondoh, N. Imazeki, K. Tanaka, T. Okada, K. Mori, A. Hada, M. Arai, T. Wakatsuki, O. Matsubara, N. Yamamoto, and M. Yamamoto Activation of the ATF6, XBP1 and grp78 genes in human hepatocellular carcinoma: a possible involvement of the ER stress pathway in hepatocarcinogenesis J. Hepatol. 38 2003 605 614
43. M. Kukla, A. Berdowska, D. Stygar, A. Gabriel, W. Mazur, B. Logiewa-Bazger, B. Sobala-Szczygiel, R.J. Buldak, M. Rokitka, W. Zajecki, L. Kepa, T. Sawczyn, and K. Zwirska-Korczala Serum FGF21 and RBP4 levels in patients with chronic hepatitis C Scand. J. Gastroenterol. 2012
44. T. Kotulak, J. Drapalova, P. Kopecky, Z. Lacinova, P. Kramar, H. Riha, I. Netuka, J. Maly, D. Housa, J. Blaha, S. Svacina, and M. Haluzik Increased circulating and epicardial adipose tissue mRNA expression of fibroblast growth factor-21 after cardiac surgery: possible role in postoperative inflammatory response and insulin resistance Physiol. Res. 60 2011 757 767
45. G. Morris-Stiff, and A.E. Feldstein Fibroblast growth factor 21 as a biomarker for NAFLD: integrating pathobiology into clinical practice J. Hepatol. 53 2010 795 796
46. A. Suomalainen, J.M. Elo, K.H. Pietilainen, A.H. Hakonen, K. Sevastianova, M. Korpela, P. Isohanni, S.K. Marjavaara, T. Tyni, S. Kiuru-Enari, H. Pihko, N. Darin, K. Ounap, L.A. Kluijtmans, A. Paetau, J. Buzkova, L.A. Bindoff, J. Annunen-Rasila, J. Uusimaa, A. Rissanen, H. Yki-Jarvinen, M. Hirano, M. Tulinius, J. Smeitink, and H. Tyynismaa FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study Lancet Neurol. 10 2011 806 818
47. H. Kurosu, M. Choi, Y. Ogawa, A.S. Dickson, R. Goetz, A.V. Eliseenkova, M. Mohammadi, K.P. Rosenblatt, S.A. Kliewer, and M. Kuro-o Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21 J. Biol. Chem. 282 2007 26687 26695
48. X. Ge, C. Chen, X. Hui, Y. Wang, K.S. Lam, and A. Xu Fibroblast growth factor 21 induces glucose transporter-1 expression through activation of the serum response factor/Ets-like protein-1 in adipocytes J. Biol. Chem. 286 2011 34533 34541
49. W. Wente, A.M. Efanov, M. Brenner, A. Kharitonenkov, A. Koster, G.E. Sandusky, S. Sewing, I. Treinies, H. Zitzer, and J. Gromada Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways Diabetes 55 2006 2470 2478
50. M.D. Sans, M.J. DiMagno, L.G. D'Alecy, and J.A. Williams Caerulein-induced acute pancreatitis inhibits protein synthesis through effects on eIF2B and eIF4F Am. J. Physiol. Gastrointestinal. Liver Physiol. 285 2003 G517 G528
51. C.L. Johnson, J.Y. Weston, S.A. Chadi, E.N. Fazio, M.W. Huff, A. Kharitonenkov, A. Koester, and C.L. Pin Fibroblast growth factor 21 reduces the severity of cerulein-induced pancreatitis in mice Gastroenterology 137 2009 1795 1804